Lack of p53 mutations and loss of heterozygosity in non-cultured human melanocytic lesions

Journal of Cancer Research and Clinical Oncology

Volumn 122, Issue 9, 1996, Pages 541-548

  Papp, Thilo ^a   Jafari, Mehrdad ^a   Schiffmann, Dietmar ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Melanoma; p53

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CONGENITAL NEVUS; CONTROLLED STUDY; DYSPLASTIC NEVUS; HETEROZYGOSITY; HUMAN; HUMAN TISSUE; MALIGNANT LENTIGO; MELANOMA; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

EID: 0029833974     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01213550     Document Type: Article

References (55)

1. Albino AP, Shea CR, McNutt NS (1992) Oncogenes in melanomas. J Dermatol 19:853-867
2. Albino AP, Vidal MJ, McNutt NS, Shea CR, Prieto VG, Nanus DM, Palmer JM, Hayward NK (1994) Mutation and expression of the p53 gene in human malignant melanoma. Melanoma Res 4:35-45
3. Barker D, Dixon K, Medrano EE, Smalara D, Im S, Mitchell D, Babcock G, Abdelmalek ZA (1995) Comparison of the responses of human melanocytes with different melanin contents to ultraviolet B radiation. Cancer Res 55:4041-4046
4. Bartek J, Bartkova J, Vojtesek B (1991) Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies. Oncogene 6:1699-1703
5. Basu-Modak S, Tyrell RM (1993) Singlet oxygen: a primary effector in the ultraviolet A near-visible light induction of the human heme oxygenase gene. Cancer Res 53:4505-4510
6. 2. Carcinogenesis 13:2003-2007
7. Brash DE, Rudolph JA, Simon JA, Lin A, McKenna GJ, Baden HP, Halperin AJ, Ponten J (1991) A role for sunlight in skin cancer: UV-induccd p53 mutations in squamous-cell carcinoma. Proc Natl Acad Sci USA 88:10124-10128
8. Brash DE, Ziegler A, Simon JA, Kunala S (1992) UV mutation spectrum in the p53 gene in basal-cell carcinoma of the skin. 83rd annual meeting of the American Association for Cancer Research. San Diego. Proc Am Assoc Cancer Res 33:671
9. Calle-Martin O de la, Fabregat V, Romero M, Soler J, Vives J, Yague J (1990) Acc-II polymorphism of the p53 gene. Nucleic Acids Res 18:4963
10. Castresana JS, Rubio MP, Vazquez JJ, Idoate M, Sober AJ, Seizinger BR, Barnhill RL (1993) Lack of allelic deletion and point mutation as mechanisms of p53 activation in human malignant melanoma, Int J Cancer 55:562-565
11. Cheng KC, Cahill DS, Kasai H, Nishimura S, Loeb LA (1992) 8-Hydroxyguanine, an abundant form of oxidative DNA damage. causes G-T and A-C substitutions. J Biol Chem 267: 166-172
12. Cristofilini M, Boi S, Girlando S (1993) p53 protein expression in nevi and melanomas. Arch Dermatol 129:739-743
13. Donehower LA, Harvey M, Slagle BL (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356:215-221
14. Dumaz N, Stary A, Soussi T, Daya-Grosjean L, Sarasin A (1994) Can we predict solar ultraviolet radiation as the causal event in human tumours by analysing the mutation spectra of the p53 gene? Mutat Res 307:375-386
15. Elwood JM (1993) Recent developments in melanoma epidemiology. Melanoma Res 3:149-156
16. Epe B (1991) Genotoxicity of singlet oxygen. Chem Biol Interact. 80:239-260
17. Epe B, Pflaum M, Boiteaux S (1993) DNA damage induced by photosensitizers in cellular and cell-free systems. Mutat Res 299:135-145
18. Erlich HA (1989) PCR technologies: principles and applications for DNA amplification. Stockton Press, New York
19. Fakharzedeh SS, Trusko SP, George DL (1991) Tumourigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumour cell line. EMBO J 10:1565-1569
20. Farmer G, Bargonetti J, Zhu H, Friedman P, Prywes R, Prywes C (1992) Wildtype p53 activates transcription in vitro. Nature 358:83-86
21. Finlay CA, Hinds PW, Tan TH (1988) Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life. Mol Cell Biol 8:531-539
22. Florenes VA, Oyjord T, Holm R, Skrede M, Borresen AL, Nesland JM, Fodstad O (1994) TP 53 allele loss. mutations and expression in malignant melanoma. Br J Cancer 69:253-259
23. Fountain JW, Bale SJ, Housman DE, Dracopoli NL (1990) Genetics of melanoma. Cancer Surv 9:645-671
24. Gaidano G. Ballerini P, Gong JZ, Inghirami G, Neri A, Newcomb EW, Magrath IT, Knowles DM, Dalla-Favera R (1991) p53 mutations in human lymplioid malignancies: Association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc Natl Acad Sci USA 88:5413-5417
25. Griffiths AJF, Miller JH, Suzuki DT, Lewontin RC, Gelbart WM (1993) An introduction to genetic analysis. Freeman, New York
26. Gruis NA, Weaver-Feldhaus J, Liu Q, Frye C, Eeles R, Orlow I, Lacombe L, Ponce-Castaneda V, Lianes P, Latres E, Skolnick M, Cordon-Cardo C, Kamb A (1995) Genetic evidence in melanoma and bladder cancers that p16 and p53 function in separate pathways of tumour suppression. Am J Pathol 146: 1199-1206
27. Harris CC (1991) Chemical and physical carcinogenesis: advances and perspectives for the 1990s. Cancer Res 51:5023s-5044s
28. Hollstein M, Sidransky D, Vogelstein B, Harris CC (1991) p53 mutations in human cancers. Science 253:49-53
29. Hollstein M, Rice K, Greenblatt MS, Soussi T, Fuchs R, Sorlie T, Hovig E, Smith-Sorensen B, Montesano R, Harris CC (1994) Database of p53 gene somatic mutations in human tumours and cell lines. Nucleic Acids Res 22:3551-3555
30. Jafari M, Papp T, Kirchner S, Diener U, Henschler D, Burg G, Schiffmann D (1995) Analysis of ras mutations in human melanocytic lesions: activation of the ras gene seems to be associated with the nodular type of malignant melanoma. J Cancer Res Clin Oncol 121:23-30
31. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW (1991) Participation of p53 in the cellular response to DNA damage. Cancer Res 51:6304-6311
32. Kern SE, Kinzler KW, Bruskin A, Jarosz D, Friedman P, Prives C, Vogelstein B (1991) Identification of p53 as a sequence-specific DNA-binding protein. Science 252:1708-1711
33. Lane DP (1992) p53. guardian of the genome. Nature 358: 15-16
34. Lane DP, Crawford L (1979) T antigen is bound to a host protein in SV40-transformed cells. Nature 278:261-263
35. Levine AJ, Momand J, Finlay CA (1991) The p53 tumour suppressor gene. Nature 351:453-456
36. Li FP, Fraumeni JF, Mulvihill JJ, Blattner WA, Dreyfuss MG, Tucker MA, Miller RW (1988) A cancer family syndrome in twenty-four kindreds. Cancer Res 48:5358-5362
37. Loganzo F, Naboya Y, Maslak P (1994) Stabilization of p53 protein is a critical response to UV radiation in human melanocytes: Implications for melanoma development. Mol Cell Differ 2: 19-39
38. Lübbe J, Reichel M, Burg G, Kleihus P (1994) Absence of p53 gene mutations in cutaneous melanoma. J Invest Dermatol 102: 819-821
39. MacGeoch C, Barnes DM, Newton JA, Mohammed S, Hogson SV, Ng M, Bishop DT, Spurr NK (1993) p53 protein detected by immunohistochemical staining is not always mutant. Dis Markers 11:239-250
40. Malkin D, Li FP, Strong LC, Fraumeni JJ, Nelson CE, Kim DH, Kassel J, Gryka MA, Bischoff FZ, Tainsky MA (1990) Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas and other neoplasms. Science 250:1233-1238
41. Montano X, Shamsher M, Whitehead P, Dawson K, Newton J (1994) Analysis of p53 in cutaneous melanoma cell lines. Oneogene 9:1455-1459
42. Nigro JM, Baker SJ, Preisinger AC (1989) Mutations in the p53 gene occur in diverse human tumour types. Nature 342:705-708
43. Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B (1992) Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358:80-83
44. Rauth S, Kichina J, Green A, Bratescu L, Das-Gupta TK (1994) Establishment of a human melanoma cell line lacking p53 expression and spontaneously metastasising in nude mouse. Anticancer Res 14:2457-2463
45. Scheffner M, Werness BA, Huibregste JM, Levine AJ, Howley PM (1990) The E6 oncoprotein encoded by human papilloma virus types 16 and 18 promotes the degradation of p53. Cell 63:1129-1136
46. Soussi T, Caron de Fromentel C, Mechali M, May P, Kress M (1987) Cloning and characterisation of a cDNA from Xenopus laertis coding for a protein homologous to human and murine p53. Oncogene 1:71-78
47. Soussi T, Caron de Fromentel C, May P (1990) Structural aspects of the p53 protein in relation to gene evolution. Oncogene 5:945-952
48. Valverde P, Healy E, Jackson I, Rees JL, Thody AJ (1995) Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans. Nat Genet 11:328-330.
49. Vogelstein B (1990) A deadly inheritance. Nature 348:681-682
50. Vogelstein B, Kinzler KW (1992) p53 function and dysfunction. Cell 70:523-526
51. Volkenandt M, Schlegel U, Nanus DM, Albino AP (1991) Mutational analysis of the p53 gene in malignant melanoma. Pigment Cell Res 4:35-40
52. Weiss J, Schweehheimer K, Cavenee WK, Herlyn M, Arden KC (1993) Mutation and expression of the p53 gene in malignant melanoma cell lines. Int J Cancer 54:693-699
53. Yamamoto F, Nishimura S, Kasai H (1992) Photosensitized formation of 8-hydroxydeoxyguanosine in cellular DNA by riboflavin. Biochem. Biophys Res Commun 187:809-813
54. Yin Y, Tainsky MA, Bischoff FZ, Strong LC, Wahl GM (1992) Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 70:937-978.
55. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A. Oren M (1991) Wild-type p53 induces apoptosis of myeloid leucaemic cells that is inhibited by interleukin-6. Nature 352:345-347